SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity.
bioRxiv
; 2021 Nov 08.
Article
en En
| MEDLINE
| ID: mdl-34790980
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
BioRxiv
Año:
2021
Tipo del documento:
Article